Resize text
Maignen, F., Hauben, M., Hung, E., Van Holle L., Dogne JM., Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases, Pharmacoepidemiology and Drug Safety, November 2013
Southworth H. - Predicting potential liver toxicity from phase 2 data: a case study with ximelagatran. - PubMed , March 2014.
Wisniewski AF, Bate A, Candore G. et al. Good Signal Detection Practices: Evidence from IMI PROTECT, Drug Safety 2016, DOI 10.1007/s40264-016-0405-1.